Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes Mellitus von Milicevic, Z

Volltext

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study von Weinstock, R S, Guerci, B, Umpierrez, G, Nauck, M A, Skrivanek, Z, Milicevic, Z

Volltext

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind... von Grunberger, G., Chang, A., Garcia Soria, G., Botros, F. T., Bsharat, R., Milicevic, Z.

Volltext

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5) von Skrivanek, Z., Gaydos, B. L., Chien, J. Y., Geiger, M. J., Heathman, M. A., Berry, S., Anderson, J. H., Forst, T., Milicevic, Z., Berry, D.

Volltext

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide von Milicevic, Z., Anglin, G., Harper, K., Konrad, R. J., Skrivanek, Z., Glaesner, W., Karanikas, C. A., Mace, K.

Volltext

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal... von Mari, A., Del Prato, S., Ludvik, B., Milicevic, Z., de la Peña, A., Shurzinske, L., Karanikas, C. A., Pechtner, V.

Volltext

1.2 - Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes Mellitus von Milicevic, Z.

Volltext

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study von Weinstock, R. S., Guerci, B., Umpierrez, G., Nauck, M. A., Skrivanek, Z., Milicevic, Z.

Volltext

А critical role for molecular chaperones in Alzheimer's disease von Milicevic, Z, Spremo-Potparevic, B, Zivkovic, L, Bajic, V

Volltext

Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression von MILICEVIC, Z, BOGOJEVIC, D, MIHAILOVIC, M, PETROVIC, M, KRIVOKAPIC, Z

Volltext

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled p... von Frias, Juan Pablo, Nauck, Michael A, Van, Joanna, Kutner, Mark E, Cui, Xuewei, Benson, Charles, Urva, Shweta, Gimeno, Ruth E, Milicevic, Zvonko, Robins, Deborah, Haupt, Axel

Volltext

Performance of aquatic weed - Waste Myriophyllum spicatum immobilized in alginate beads for the removal of Pb(II) von Milojković, Jelena V., Lopičić, Zorica R., Anastopoulos, Ioannis P., Petrović, Jelena T., Milićević, Sonja Z., Petrović, Marija S., Stojanović, Mirjana D.

Volltext

P314 Évaluation des principaux résultats du dulaglutide en administration hebdomadaire comparé à l’insuline glargine, tous deux associés à l’insuline prandiale lispro, selon le tau... von Adetunji, O, Jung, H, Jia, N, Milicevic, Z

Volltext

Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels von Wen, Y, Lemen, D, Chen, Y, Lin, Y, Thomas, M, Hartman, M, Coskun, T, Milicevic, Z, Haupt, A, Ruotolo, G, Konrad, R

Volltext

Triple-hormone receptor agonist retatrutide significantly improves lipoprotein and apolipoprotein profiles in participants with obesity or overweight von Nicholls, S, Pirro, V, Lin, Y, Wilson, J, Duffin, K, Zhen, E, Harris, C, Thomas, M, Hartman, M, Coskun, T, Milicevic, Z, Haupt, A, Ruotolo, G

Volltext

Mechanism of stearic acid adsorption to calcite von Mihajlović, Slavica R., Vučinić, Dušica R., Sekulić, Živko T., Milićević, Sonja Z., Kolonja, Božo M.

Volltext

THE EFFECT OF TIRZEPATIDE DURING WEIGHT LOSS ON FOOD INTAKE, APPETITE, FOOD PREFERENCE AND FOOD CRAVING IN PEOPLE WITH OBESITY von Martin, C., Ravussin, E., Sanchez-Delgado, G., Nishiyama, H., Li, J., Urva, S., Pratt, E., Milicevic, Z., Haupt, A., Coskun, T., Longuet, C.

Volltext

A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan von Mattoo, V., Milicevic, Z., Malone, J.K., Schwarzenhofer, M., Ekangaki, A., Levitt, L.K., Liong, L.H.C., Rais, N., Tounsi, H.

Volltext

THE EFFECT OF TIRZEPATIDE DURING WEIGHT LOSS ON FOOD INTAKE, APPETITE, FOOD PREFERENCE AND FOOD CRAVING IN PEOPLE WITH OBESITY von Martin, C., Ravussin, E., Sanchez-Delgado, G., Nishiyama, H., Li, J., Urva, S., Pratt, E., Milicevic, Z., Haupt, A., Coskun, T., Longuet, C.

Volltext

Continuous glucose monitoring in type 2 diabetes patients treated with once weekly dulaglutide or once daily glargine, both combined with insulin lispro (AWARD-4 substudy) von Jendle, Johan, Testa, M., Martin, S., Jiang, H., Milicevic, Z.

Volltext